PharmaCielo Ltd.
PCLO.V
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -933.50K | 292.20K | -1.01M | -940.30K | -1.65M |
| Total Depreciation and Amortization | 619.20K | 314.30K | 61.80K | 14.50K | 300.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -2.39M | 164.30K | 861.00K | 926.90K | 355.30K |
| Change in Net Operating Assets | 25.40K | -390.10K | -2.48M | 1.53M | 764.90K |
| Cash from Operations | -2.68M | 380.70K | -2.56M | 1.53M | -233.60K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | 2.41M | -540.40K | 5.38M | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 22.90K |
| Cash from Investing | 2.41M | -540.40K | 5.38M | -- | 22.90K |
| Total Debt Issued | 115.00K | 150.00K | 25.00K | 125.00K | 405.00K |
| Total Debt Repaid | 0.00 | 102.00K | -3.67M | -2.29M | -89.00K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 82.70K | 180.80K | -2.65M | -1.56M | 220.20K |
| Foreign Exchange rate Adjustments | -9.10K | 2.40K | 10.10K | -1.50K | 6.40K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -195.40K | 23.40K | 181.50K | -34.40K | 15.90K |